Cost-effectiveness analyses and utility weights
Published cost-effectiveness analyses and health-state utility weights that a model of this product could cite, adapt, or compare against, grouped by how each article relates to the product and its indication. Every value is quoted from the article it cites, and section 3 lists the searches that found the articles.
0 cost-effectiveness analyses and 0 studies reporting utility weights · 0 sources
Overview
| Item | Detail |
|---|---|
| Literature searched | Tufts Medical Center Cost-Effectiveness Analysis Registry, searched October 21, 2026; the queries are listed in section 3. |
| Cost-effectiveness analyses | 0 |
| Studies reporting utility weights | 0 |
Cost-effectiveness analyses
Analyses of Dersimelagon (MT-7117)
No evidence found.
Treatments for the same indication
No evidence found.
The same disease in other populations or settings
No evidence found.
Related diseases and analogous treatments
No evidence found.
Utility weights
Utility weights from analyses of Dersimelagon (MT-7117)
No evidence found.
Utility weights for the same indication
No evidence found.
Utility weights for the same disease in other populations or settings
No evidence found.
Utility weights for related diseases and analogous treatments
No evidence found.
Search strategy
| Dataset | Query | Results |
|---|---|---|
| Ratios | dersimelagon OR "MT-7117" OR afamelanotide OR Scenesse OR protoporphyria | 0 |
| Methods | dersimelagon OR afamelanotide OR protoporphyria OR "melanocortin" | 0 |
| Weights | protoporphyria OR porphyria OR afamelanotide OR "phototoxicity" OR "photosensitivity" | 1 |
| Ratios | givosiran OR "acute hepatic porphyria" OR "acute intermittent porphyria" OR hemin | 0 |
| Ratios | vitiligo OR "polymorphous light eruption" OR "polymorphic light eruption" OR "solar urticaria" | 0 |
| Weights | "DLQI" OR "Dermatology Life Quality Index" | 9 |
| Ratios | porphyria OR "erythropoietic" | 4 |
| Methods | porphyria OR "light sensitivity" OR "sunlight exposure" | 0 |